Taken together, these results suggested that MDM2-p53 was a crucial downstream factor of IDO1, and IDO1 might play tumor-promoting roles via the MDM2-p53 pathway, including the p53-related cell cycle and apoptotic pathway. The gene discussed is IDO1; the disease is neoplasm.